CA Patent

CA3112277A1 — Crystal form of gsk1278863 and preparation method and pharmaceutical use thereof

Assigned to GlaxoSmithKline Intellectual Property No 2 Ltd · Expires 2019-03-21 · 7y expired

What this patent protects

Crystal forms of a hypoxia-inducible factor prolyl hydroxylase inhibitor compound (I) GSK1278863, CS1 and CS9, preparation methods thereof, and uses of the same in preparing a pharmaceutical preparation for treating and/or preventing anemia.

USPTO Abstract

Crystal forms of a hypoxia-inducible factor prolyl hydroxylase inhibitor compound (I) GSK1278863, CS1 and CS9, preparation methods thereof, and uses of the same in preparing a pharmaceutical preparation for treating and/or preventing anemia.

Drugs covered by this patent

Patent Metadata

Patent number
CA3112277A1
Jurisdiction
CA
Classification
—
Expires
2019-03-21
Drug substance claim
No
Drug product claim
No
Assignee
GlaxoSmithKline Intellectual Property No 2 Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.